CYTOGENETIC ONCOLOGY PROGRAM PROJECT

  • Alberts, David S (PI)
  • Leibovitz, Albert (PI)
  • Meyskens, Frank (PI)
  • Moon, Thomas (PI)
  • Meltzer, Paul (PI)
  • Vogelstein, Bert (PI)
  • Dalton, William (PI)
  • Sandberg, Avery (PI)
  • McGee, Daniel (PI)
  • Davis, John (PI)
  • Trent, Jeffrey (PI)
  • Salmon, Sydney (PI)
  • Taetle, Raymond (PI)

Project: Research project

Project Details

Description

The overall goal of this Program Project is to greatly expand our
understanding of the clinical significance of cytogenetic change in
human cancer. Our approach will be to correlate laboratory studies with
important clinical features in a multidisciplinary research effort.
Experts in the areas of cancer cytogenetics, molecular biology,
medical oncology, cell culture, tumor pathology, and biostatistics
have been assembled and will focus on studies of: clinical
correlations of chromosome changes and cytogenetic and
molecular biologic analysis of acquired drug resistance.
StatusFinished
Effective start/end date1/1/875/31/96

Funding

  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health

ASJC

  • Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.